Korean

R&D Highlights

R&D Pipeline
R&D
HOME >  R&D Highlights >  R&D

Multi-Component
Multi-Target (MCMT) Approach

  • ·

    Solving the limitations of single-target
    treatment for chronic incurable diseases

  • ·

    Development of disease modifying
    natural drug products to treat chronic
    incurable diseases

Platform Technology

  • ·

    AI-based big data system and
    multi-omics analysis system analysis

  • ·

    Cutting edge CMC technology
    which coincides with FDA regulations

SyMthomics

  • ·

    Multi-omics analysis based on AI-networking
    modeling using virtual human body system
    and clinical basis

  • ·

    Prediction of clinical efficacy by identifying
    multi-components and mode of action(MoA)

Multi-Modality

  • ·

    Multi-component material using extracellular
    vesicle of microbiome, exosome, etc.

  • ·

    Development of candidate material
    to maximize clinical efficacy